Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long Term Outcome of Argon Plasma Coagulation of Cervical Heterotopic Gastric Mucosa as an Alternative Treatment for Globus Sensations (ACHAT FU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01574755
Recruitment Status : Completed
First Posted : April 10, 2012
Last Update Posted : July 2, 2013
Sponsor:
Information provided by (Responsible Party):
Technische Universität München

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
APC of gastric inlet patches is successful for the treatment of globus sensations in the throat (Bajbouj et al Gastroenterology 2009; 137:440-4). There is no data for long term efficiency of this treatment. To measure long term efficacy all patients treated with this therapy in our clinic were followed up with complaint-evaluation sheets and endoscopy.

Condition or disease
Globus Sensations in the Throat

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 49 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Long Term Outcome of Argon Plasma Coagulation of Cervical Heterotopic Gastric Mucosa as an Alternative Treatment for Globus Sensations
Study Start Date : September 2011
Actual Primary Completion Date : February 2012
Actual Study Completion Date : February 2012

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Change of globus complaint score [ Time Frame: retrospectively assessed: before APC therapy and at the date of follow up ]

Biospecimen Retention:   Samples Without DNA
biopsy of gastric inlet patches

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
outpatient clinic of a university hospital
Criteria

Inclusion Criteria:

  • former APC therapy of gastric inlet patches as treatment for globus sensations
  • at least 6 month since last APC therapy

Exclusion Criteria:

  • patients with reduced general condition
  • malignancy of the upper gastrointestinal tract
  • patients older than 80 years
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01574755


Sponsors and Collaborators
Technische Universität München
Investigators
Layout table for investigator information
Principal Investigator: Peter Klare, MD Departmet for Internal Medicine and Gastroenterology, Technical University Munich, Germany
Study Chair: Alexander Meining, Professor Department for Internal Medicine and Gastroenterology, Technical University Munich, Germany
Study Director: Monther Bajbouj, Assistent Professor Department for Internal Medicine and Gastroenterology, Technical University Munich, Germany
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Technische Universität München
ClinicalTrials.gov Identifier: NCT01574755    
Other Study ID Numbers: ACHAT-FU-1
First Posted: April 10, 2012    Key Record Dates
Last Update Posted: July 2, 2013
Last Verified: June 2013
Keywords provided by Technische Universität München:
gastric inlet patches
argon plasma coagulation
globus sensations
Additional relevant MeSH terms:
Layout table for MeSH terms
Conversion Disorder
Somatoform Disorders
Mental Disorders